Lucid Diagnostics Inc (NASDAQ:LUCD) shares, rose in value on Friday, March 07, without any change to the previous day’s close as strong demand from buyers drove the stock to $1.39.
Actively observing the price movement in the last trading, the stock closed the session at $1.39. Referring to stock’s 52-week performance, its high was $1.63, and the low was $0.63. On the whole, LUCD has fluctuated by 46.36% over the past month.
With the market capitalization of Lucid Diagnostics Inc currently standing at about $82.49 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 4.57M, with a low estimate of 1.22M and a high estimate of 1.68M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.42M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that LUCD’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of LUCD currently trading nearly -0.41% and 29.73% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 58.61, while the 7-day volatility ratio is showing 10.71% which for the 30-day chart, stands at 12.98%. Furthermore, Lucid Diagnostics Inc (LUCD)’s beta value is 1.33, and its average true range (ATR) is 0.13.
A comparison of Lucid Diagnostics Inc (LUCD) with its peers suggests the former has fared considerably weaker in the market. LUCD showed an intraday change of 0.00% in last session, and over the past year, it grew by 14.88%%.
Data on historical trading for Lucid Diagnostics Inc (NASDAQ:LUCD) indicates that the trading volumes over the past 3 months, they’ve averaged 558.33K. According to company’s latest data on outstanding shares, there are 51.60 million shares outstanding.
Nearly 62.03% of Lucid Diagnostics Inc’s shares belong to company insiders and institutional investors own 7.60% of the company’s shares. The stock has risen by 69.78% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the LUCD stock heading into the next quarter.
